Reply: Duration of the Double Antiplatelet Therapy in Patients With Coronary and Peripheral Arterial Disease: The Key Might Be in the Type of Drug.

Secemsky EA, Yeh RW, Mauri L, Investigators DS. Reply: Duration of the Double Antiplatelet Therapy in Patients With Coronary and Peripheral Arterial Disease: The Key Might Be in the Type of Drug.. JACC. Cardiovascular interventions. 2017;10(14):1468–1469. PMID: 28728663
Publisher's Version
Last updated on 08/23/2023
PubMed